BIOLIFE SOLUTIONS INC's ticker is BLFS and the CUSIP is 09062W204. A total of 162 filers reported holding BIOLIFE SOLUTIONS INC in Q2 2022. The put-call ratio across all filers is 86.50 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $138,832 | -37.5% | 10,053 | 0.0% | 0.03% | -37.0% |
| Q2 2023 | $222,171 | +11.8% | 10,053 | 0.0% | 0.05% | +8.0% |
| Q1 2023 | $198,748 | -1.2% | 10,053 | -9.0% | 0.05% | -20.6% |
| Q4 2022 | $201,165 | -19.9% | 11,053 | 0.0% | 0.06% | -28.4% |
| Q3 2022 | $251,000 | +64.1% | 11,053 | 0.0% | 0.09% | +72.5% |
| Q2 2022 | $153,000 | -44.4% | 11,053 | -8.6% | 0.05% | -45.2% |
| Q1 2022 | $275,000 | -33.4% | 12,092 | +9.0% | 0.09% | -28.5% |
| Q4 2021 | $413,000 | -11.9% | 11,092 | 0.0% | 0.13% | -18.8% |
| Q3 2021 | $469,000 | -83.2% | 11,092 | -82.3% | 0.16% | -83.7% |
| Q2 2021 | $2,797,000 | +176.7% | 62,842 | +123.7% | 0.98% | +163.9% |
| Q1 2021 | $1,011,000 | -86.4% | 28,093 | -84.9% | 0.37% | -86.4% |
| Q4 2020 | $7,435,000 | -0.2% | 186,392 | -27.6% | 2.72% | -5.5% |
| Q3 2020 | $7,449,000 | -58.6% | 257,389 | -76.6% | 2.88% | -61.7% |
| Q2 2020 | $17,985,000 | +72.1% | 1,100,000 | 0.0% | 7.51% | +47.8% |
| Q1 2020 | $10,450,000 | – | 1,100,000 | – | 5.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 7,566,292 | $171,982,000 | 7.71% |
| Gagnon Advisors, LLC | 205,968 | $4,682,000 | 2.16% |
| Ranger Investment Management | 1,300,407 | $29,558,000 | 1.87% |
| GAGNON SECURITIES LLC | 379,506 | $8,626,000 | 1.41% |
| Zweig-DiMenna Associates LLC | 376,550 | $8,559,000 | 1.14% |
| Meros Investment Management, LP | 48,504 | $1,102,000 | 0.87% |
| Mesirow Financial Investment Management, Inc. | 10,526 | $239,000 | 0.81% |
| Penbrook Management LLC | 48,615 | $1,105,000 | 0.72% |
| MOODY ALDRICH PARTNERS LLC | 220,680 | $5,016,000 | 0.70% |
| GENEVA CAPITAL MANAGEMENT LLC | 1,456,656 | $33,110,000 | 0.64% |